Form 4 for BNGO Bionano Genomics, Inc.
Accepted 2024-06-05 00:00:00 ET · period of report 2024-06-03 · accession 0001415889-24-015624 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-05 | 2024-06-03 | BNGO | OLDAKOWSKI MARK | COO | A - Grant | $0.00 | +16.0K | 64.7K | +33% | $0 |
| D | 2024-06-05 | 2024-06-03 | BNGO | OLDAKOWSKI MARK | COO | A - Grant | $0.00 | +75.0K | 75.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-03 | A | A | 16,000 | $0.00 | 64,698 | D | — | — | (F2) The shares subject to the RSUs vest 1/4th annually beginning on the one-year anniversary of the grant date. (F1) Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan. (F3) Includes 54 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on June 9, 2023. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-06-03 | A | A | 75,000 | $0.00 | 75,000 | D | $0.93 · — to 2034-06-02 | 75,000 Common Stock | (F4) The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of June 3, 2024 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date. |